关键数据
23.900今开
24.265最高
71.72K成交量
亏损市盈率 TTM
45.74市盈率动
--股息TTM
0.14%换手率
24.160昨收
23.370最低
1.69M成交额
亏损市盈率静
3.23市净率
0.00%股息率 TTM
-4.63%ROA
35.87052周最高
0.07量比
-20.21M净利润
50.12M总股本
-0.4200每股收益TTM
1.23Beta
-5.99%ROE
15.59052周最低
3.70%振幅
74.09%毛利率
1.18B总市值
2.90回报/风险
3.48%风险率

即将为您带来更多新闻,敬请期待。。。
STAAR Surgical Co评分
0.10与上次评分对比预测6.50
财务诊断8.56
技术分析4.95
公司估值7.87
机构认同度10.00
风险评估6.70
分析师评级
持有评级
27.900目标均价
+18.88%涨幅空间
STAAR Surgical Co 最新财报电话会记录
STAAR Surgical (STAA) 2026财年第二季度业绩电话会:中国市场与EVO Plus推动销售额增长111%
在中国市场和EVO Plus的推动下,STAAR Surgical 2026财年第二季度销售额增长111%至9350万美元。净利润达到810万美元,现金增加至1.815亿美元。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
STAAR Surgical Co 简介
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
行业医疗设备与耗材
公司代码STAA
员工数量1157
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Broadwood Capital, Inc. | 32.38% |
|---|
| BlackRock Institutional Trust Company, N.A. | 13.44% |
|---|
| Yunqi Capital Limited | 6.54% |
|---|
| Madison Avenue Partners LP | 5.73% |
|---|
| 股东类型 | 占比 |
|---|
| Hedge Fund | 53.68% |
|---|
| Investment Advisor | 31.49% |
|---|
| Investment Advisor/Hedge Fund | 21.11% |
|---|
| Research Firm | 6.23% |
|---|
常见问题
STAAR Surgical Co(STAA)的当前股价是多少?
STAAR Surgical Co(STAA)的当前股价是 23.62。
STAAR Surgical Co的股票代码是什么?
STAAR Surgical Co的股票代码是STAA。
STAAR Surgical Co股票的52周最高点是多少?
STAAR Surgical Co股票的52周最高点是35.87。
STAAR Surgical Co股票的52周最低点是多少?
STAAR Surgical Co股票的52周最低点是15.59。
STAAR Surgical Co的市值是多少?
STAAR Surgical Co的市值是1.18B。
现在STAAR Surgical Co(STAA)的股票是买入、持有还是卖出?
根据分析师评级,STAAR Surgical Co(STAA)的总体评级为signal_hold,目标价格为27.90。
STAAR Surgical Co(STAA)股票的每股收益(EPS TTM)是多少
STAAR Surgical Co(STAA)股票的每股收益(EPS TTM)是-0.42。